UMass Chan cancer biologist receives New Innovator Award for developing DNA sequencing technology
William Flavahan, PhD, is one of 40 recipients of the $1.5 million NIH Director’s New Innovator Award, designed to support early career investigators who are proposing bold research.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Award, Research, Molecular, Cell and Cancer Biology, Latest News, William Flavahan,
Recent Publications
Hegde et al. The co-receptor Neuropilin-1 enhances proliferation in inv(16) acute myeloid leukemia via VEGF signaling. Leukemia, 2025. Article | Castilla Lab
Banday et al. The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma. Nat Commun, 2025. Article | Green Lab
Whalen et al. Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerability. Nat Cancer, 2025. Article | Cantor Lab
Hitha Gopalan Nair, Ph.D. - Cantor Lab “Dissecting the role of BRCA1 in Lagging strand synthesis ” Chaitanya Naimesh Parikh - Ruscetti Lab “Modulating the Immunosuppressive Pancreas Tumor Microenvironment through Intratumoral Delivery of Cytokine